-
Soliris 300 mg (Eculizumab)
Call for PriceSoliris 300 mg (Eculizumab) — complement-inhibitor biologic for PNH, aHUS, gMG, and NMOSD. Institutional pricing on enquiry.
Soliris 300 mg (Eculizumab) — complement-inhibitor biologic for PNH, aHUS, gMG, and NMOSD. Institutional pricing on enquiry.
Call for Discounts